Composition for treatment and/or prevention of a corona virus infection
AssigneeDr. Kurt Wolff GmbH & Co. KG
InventorsErik Schulze Zur Wiesche, Miriam Stark, Eduard Richard Doerrenberg
Life of this patent
Estimating the term…
Abstract
The invention relates to a topical composition having a low anionic surfactant amount for use in the treatment and/or prevention of a corona virus infection.
Claims20
A composition comprising at least two anionic surfactants A and B in a weight ratio A/B from 10/1 to 1.1/1, wherein surfactant A is an alkyl sulfate and surfactant B is selected from alkyl sulfates, alkyl sarcosinates, and alkyl taurates, wherein the total amount of anionic surfactants in the composition is 1 wt.-% or less.
A composition comprising
- 0.001 to 20 wt.-% of a water-soluble zinc salt selected from the group consisting of zinc-L-pyrrolidone-carboxylate, zinc acetate, zinc chloride, zinc histidine, zinc gluconate, zinc aspartate, zinc citrate, zinc sulfate, zinc lactate and mixtures thereof,
- 0.001 to 1 wt.-% of a total amount of anionic surfactants, comprising at least two anionic surfactants A and B in a weight ratio A/B from 10/1 to 1.1/1, wherein surfactant A is an alkyl sulfate and surfactant B is selected from alkyl sulfates, alkyl sarcosinates, and alkyl taurates, and
- 0.001 to 5 wt.-% of a polyalcohol selected from erythritol, arabitol, lactitol, maltitol, mannitol, sorbitol, xylitol, and mixtures thereof.
A method for treating a corona virus infection or reducing the probability of a corona virus infection, comprising administering a composition to a subject, wherein the composition comprises at least two anionic surfactants A and B in a weight ratio A/B from 10/1 to 1.1/1, wherein surfactant A is an alkyl sulfate and surfactant B is selected from alkyl sulfates, alkyl sarcosinates, and alkyl taurates, wherein the total amount of anionic surfactants in the composition is 1 wt.-% or less.
Dependencies are inferred from the claim text.